The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 60% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it strong buy, with a mean price target of $38.
Constellium SE
CSTM · the NYSE · USD · Market cap $3.3B · 11,500 employees
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industria…
FAIL · Does not pass the screenScreen close, 2026-10-01 · not a live quote
Last reviewed 6 days ago
Screened 2026-10-01 · the tape above runs as of 01:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 24.66 against the desk's fair-value range, base estimate 29.46, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Constellium SE holds its Markdown at $24.66. Consolidating, no directional conviction, held for 50 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 50 days |
| Price at the screen | $24.66 |
| Valuation | 6.37 trailing · 8.94 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.55 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 36.31% | Below 33% | Interest-bearing debt is 36.3% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 13.65% | Below 49% | Money owed to the company is 13.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Constellium SE's business is in a permissible area, but its interest-bearing debt is about 36% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-07. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-10-01 screen. The gold marker is the market price at the same screen. A 19.5% margin of safety to the base estimate.
Third-party analyst targets: 5 covering, consensus Strong Buy. The average target sits +44% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-01 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAluminium Cycles Turn Cheap Valuations Into Traps
Every plane that flies or can that gets crushed relies on aluminium rolling through factories that boom then bust with the economy. Constellium shows a 24% revenue jump, 46% ROE and a forward multiple of just 9.6 times, yet opportunity sits at none because this is exactly how cyclical aluminium names flash peak earnings before the next downturn arrives.
The business clears our ethical screen and carries a 5% profit margin across aerospace and packaging work, but an unknown moat leaves it exposed when input costs or demand swing hard. Analysts see upside to 37 dollars, yet the 10% gap to our fair value of 30.85 dollars does not overcome the pattern of low multiples marking the top of the cycle rather than a bargain.
Risk sits in those swings, where strong recent returns can vanish fast once volumes slow and margins compress. The low multiple here is a warning, not an invitation. Analysis, not advice.
| Forward P/E | 8.9xcheap for a company growing this fast |
| Trailing P/E | 6.4xvery cheap relative to earnings |
| EPS, trailing | 3.87 |
| EPS, forward | 2.76 |
| Revenue growth | +30.7%strong top-line growth |
| Profit margin | 5.7%thin but positive margins |
| Return on equity | 53.1%an exceptional return on shareholder capital |
| FCF yield | 1.60% |
| Debt to equity | 1.53a meaningful debt load worth watching |
| Current ratio | 1.43adequate liquidity, worth monitoring |
| Beta | 1.55much more volatile than the market |
| Short interest, float | 0.05% |
| 52-week range | 14.39 - 36.99 |
| Market cap | $3.3B |
| Employees | 11,500 |
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to France and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCSTM trades on the NYSE (the company is based in France). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 60% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it strong buy, with a mean price target of $38.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 21.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it strong buy, with a mean price target of $38.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 138%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it strong buy, with a mean price target of $38.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- How Constellium’s Upgraded 2026 Guidance and Earnings Outlook Will Impact Constellium (CSTM) Investors Simply Wall St. · 18d ago
- Constellium (CSTM) Raises 2026 Guidance As The Pullback Tests Its Undervalued Narrative Simply Wall St. · 19d ago
- Constellium highlighted as Zacks Bull and AGCO Bear of the Day Zacks · 20d ago
- Bull of the Day: Constellium (CSTM) Zacks · 20d ago
- Is Constellium (CSTM) Stock Outpacing Its Industrial Products Peers This Year? Zacks · 29d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $34.20 | -4.8% | · | $952 | -4.8% |
| 2 months | $29.64 | +9.8% | · | $1,098 | +9.8% |
| 3 months | $24.59 | +32.4% | · | $1,324 | +32.4% |
| 6 months | $18.53 | +75.7% | · | $1,757 | +75.7% |
| 1 year | $13.65 | +138.5% | · | $2,385 | +138.5% |
| 2 years | $20.20 | +61.1% | · | $1,611 | +61.1% |
| 3 years | $15.94 | +104.2% | · | $2,042 | +104.2% |
| 5 years | $20.07 | +62.2% | · | $1,622 | +62.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CSTM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.